Literature DB >> 17680022

Pharmacokinetics of melphalan in myeloma patients undergoing an autograft.

C E Nath, P J Shaw, J Trotman, L Zeng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17680022     DOI： 10.1038/sj.bmt.1705797

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant.

Authors:  Karen Sweiss; Bhaskar Vemu; Craig C Hofmeister; Eric Wenzler; Gregory Sampang Calip; John P Galvin; Nadim Mahmud; Damiano Rondelli; Jeremy James Johnson; Pritesh Patel
Journal:  Br J Clin Pharmacol       Date:  2020-05-01       Impact factor: 4.335

2.  Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma.

Authors:  Karen Sweiss; Gregory S Calip; Jeremy J Johnson; Damiano Rondelli; Pritesh R Patel
Journal:  Bone Marrow Transplant       Date:  2019-08-06       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.